197 related articles for article (PubMed ID: 30718954)
1. A multifunctional-targeted nanoagent for dual-mode image-guided therapeutic effects on ovarian cancer cells.
Chen C; Sun J; Chen S; Liu Y; Zhu S; Wang Z; Chang S
Int J Nanomedicine; 2019; 14():753-769. PubMed ID: 30718954
[TBL] [Abstract][Full Text] [Related]
2. Folate-Targeted and Oxygen/Indocyanine Green-Loaded Lipid Nanoparticles for Dual-Mode Imaging and Photo-sonodynamic/Photothermal Therapy of Ovarian Cancer in Vitro and in Vivo.
Liu Y; Chen S; Sun J; Zhu S; Chen C; Xie W; Zheng J; Zhu Y; Xiao L; Hao L; Wang Z; Chang S
Mol Pharm; 2019 Oct; 16(10):4104-4120. PubMed ID: 31517495
[TBL] [Abstract][Full Text] [Related]
3. Oxygen and indocyanine green loaded phase-transition nanoparticle-mediated photo-sonodynamic cytotoxic effects on rheumatoid arthritis fibroblast-like synoviocytes.
Tang Q; Cui J; Tian Z; Sun J; Wang Z; Chang S; Zhu S
Int J Nanomedicine; 2017; 12():381-393. PubMed ID: 28123298
[TBL] [Abstract][Full Text] [Related]
4. The Destruction Of Laser-Induced Phase-Transition Nanoparticles Triggered By Low-Intensity Ultrasound: An Innovative Modality To Enhance The Immunological Treatment Of Ovarian Cancer Cells.
Xie W; Zhu S; Yang B; Chen C; Chen S; Liu Y; Nie X; Hao L; Wang Z; Sun J; Chang S
Int J Nanomedicine; 2019; 14():9377-9393. PubMed ID: 31819438
[TBL] [Abstract][Full Text] [Related]
5. Lipoparticles for Synergistic Chemo-Photodynamic Therapy to Ovarian Carcinoma Cells: In vitro and in vivo Assessments.
Ali S; Amin MU; Tariq I; Sohail MF; Ali MY; Preis E; Ambreen G; Pinnapireddy SR; Jedelská J; Schäfer J; Bakowsky U
Int J Nanomedicine; 2021; 16():951-976. PubMed ID: 33603362
[TBL] [Abstract][Full Text] [Related]
6. Dual-mode imaging and therapeutic effects of drug-loaded phase-transition nanoparticles combined with near-infrared laser and low-intensity ultrasound on ovarian cancer.
Chen S; Liu Y; Zhu S; Chen C; Xie W; Xiao L; Zhu Y; Hao L; Wang Z; Sun J; Chang S
Drug Deliv; 2018 Nov; 25(1):1683-1693. PubMed ID: 30343601
[TBL] [Abstract][Full Text] [Related]
7. Iron(II) phthalocyanine Loaded and AS1411 Aptamer Targeting Nanoparticles: A Nanocomplex for Dual Modal Imaging and Photothermal Therapy of Breast Cancer.
He Y; Wang M; Fu M; Yuan X; Luo Y; Qiao B; Cao J; Wang Z; Hao L; Yuan G
Int J Nanomedicine; 2020; 15():5927-5949. PubMed ID: 32848397
[TBL] [Abstract][Full Text] [Related]
8. Nanosonosensitizers for Highly Efficient Sonodynamic Cancer Theranostics.
Huang J; Liu F; Han X; Zhang L; Hu Z; Jiang Q; Wang Z; Ran H; Wang D; Li P
Theranostics; 2018; 8(22):6178-6194. PubMed ID: 30613291
[No Abstract] [Full Text] [Related]
9. Phase-shift, targeted nanoparticles for ultrasound molecular imaging by low intensity focused ultrasound irradiation.
Li M; Luo H; Zhang W; He K; Chen Y; Liu J; Chen J; Wang D; Hao L; Ran H; Zheng Y; Wang Z; Li P
Int J Nanomedicine; 2018; 13():3907-3920. PubMed ID: 30013344
[TBL] [Abstract][Full Text] [Related]
10. hTERT-molecular targeted therapy of ovarian cancer cells via folate-functionalized PLGA nanoparticles co-loaded with MNPs/siRNA/wortmannin.
Ghareghomi S; Ahmadian S; Zarghami N; Hemmati S
Life Sci; 2021 Jul; 277():119621. PubMed ID: 34004255
[TBL] [Abstract][Full Text] [Related]
11. A laser-activated multifunctional targeted nanoagent for imaging and gene therapy in a mouse xenograft model with retinoblastoma Y79 cells.
Wu M; Xiong H; Zou H; Li M; Li P; Zhou Y; Xu Y; Jian J; Liu F; Zhao H; Wang Z; Zhou X
Acta Biomater; 2018 Apr; 70():211-226. PubMed ID: 29452275
[TBL] [Abstract][Full Text] [Related]
12. Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon.
Wu P; Zhou Q; Zhu H; Zhuang Y; Bao J
BMC Cancer; 2020 Apr; 20(1):354. PubMed ID: 32345258
[TBL] [Abstract][Full Text] [Related]
13. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
14. NIR Laser Responsive Nanoparticles for Ovarian Cancer Targeted Combination Therapy with Dual-Modal Imaging Guidance.
Zhao J; Zhang L; Qi Y; Liao K; Wang Z; Wen M; Zhou D
Int J Nanomedicine; 2021; 16():4351-4369. PubMed ID: 34234430
[TBL] [Abstract][Full Text] [Related]
15. NIR-Light-Triggered Anticancer Strategy for Dual-Modality Imaging-Guided Combination Therapy via a Bioinspired Hybrid PLGA Nanoplatform.
Shen X; Li T; Chen Z; Xie X; Zhang H; Feng Y; Li S; Qin X; Yang H; Wu C; Zheng C; Zhu J; You F; Liu Y
Mol Pharm; 2019 Mar; 16(3):1367-1384. PubMed ID: 30776896
[TBL] [Abstract][Full Text] [Related]
16. Paclitaxel/methotrexate co-loaded PLGA nanoparticles in glioblastoma treatment: Formulation development and in vitro antitumor activity evaluation.
Madani F; Esnaashari SS; Bergonzi MC; Webster TJ; Younes HM; Khosravani M; Adabi M
Life Sci; 2020 Sep; 256():117943. PubMed ID: 32531377
[TBL] [Abstract][Full Text] [Related]
17. Cell-penetrating Peptide-modified Targeted Drug-loaded Phase-transformation Lipid Nanoparticles Combined with Low-intensity Focused Ultrasound for Precision Theranostics against Hepatocellular Carcinoma.
Zhao H; Wu M; Zhu L; Tian Y; Wu M; Li Y; Deng L; Jiang W; Shen W; Wang Z; Mei Z; Li P; Ran H; Zhou Z; Ren J
Theranostics; 2018; 8(7):1892-1910. PubMed ID: 29556363
[No Abstract] [Full Text] [Related]
18. Shikonin-loaded antibody-armed nanoparticles for targeted therapy of ovarian cancer.
Matthaiou EI; Barar J; Sandaltzopoulos R; Li C; Coukos G; Omidi Y
Int J Nanomedicine; 2014; 9():1855-70. PubMed ID: 24790428
[TBL] [Abstract][Full Text] [Related]
19. Dual-Functional PLGA Nanoparticles Co-Loaded with Indocyanine Green and Resiquimod for Prostate Cancer Treatment.
Lin W; Li C; Xu N; Watanabe M; Xue R; Xu A; Araki M; Sun R; Liu C; Nasu Y; Huang P
Int J Nanomedicine; 2021; 16():2775-2787. PubMed ID: 33880023
[TBL] [Abstract][Full Text] [Related]
20. Hyaluronic acid-decorated PLGA-PEG nanoparticles for targeted delivery of SN-38 to ovarian cancer.
Vangara KK; Liu JL; Palakurthi S
Anticancer Res; 2013 Jun; 33(6):2425-34. PubMed ID: 23749891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
